At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...

The University of California and the University of Vienna on Monday convinced a U.S. appeals court to revive their bid for ...

The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR ...

In a precedential opinion issued on Monday, the U.S. Court of Appeals for the Federal Circuit (CAFC) vacated and remanded a ...

Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that the U.S. Court of Appeals for ...

The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 ...

Since its discovery in 2011, CRISPR-Cas 9 has revolutionized medicine. One of the companies at the forefront of this ...

Globally, people get animal protein mostly from chickens, with pigs and cattle in second and third place. A 2023 report ...

CRISPR Therapeutics’ partner Vertex reported that more than 65 treatment centers have been activated for the gene therapy ...

Emma Dimery joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

PIC's gene-edited pigs are highly resistant to one of the most harmful viruses affecting pig populations worldwide today.